Previous Section
Clinical Trials
21. Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes.
- Author
- Maina G; Albert U; Bellodi L; Colombo C; Faravelli C; Monteleone P; Bogetto F; Cassano GB; Maj M;
- Institution
- Department of Neurosciences, Mood and Anxiety Disorders Unit, University of Turin, Italy. giuseppemaina@hotmail.com
- Journal
- J Clin Psychiatry. 2007 Feb;68(2):207-12.
- Abstract URL
- Click here to view abstract
22. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.
- Author
- Cookson J; Keck PE Jr; Ketter TA; Macfadden W;
- Institution
- The Department of Psychiatry, Royal London Hospital, London, UK. john.cookson@elcmht.nhs.uk
- Journal
- Int Clin Psychopharmacol. 2007 Mar;22(2):93-100.
- Abstract URL
- Click here to view abstract
23. A 2-year, open-label pilot study of adjunctive chromium in patients with treatment-resistant rapid-cycling bipolar disorder.
- Author
- Amann BL; Mergl R; Vieta E; Born C; Hermisson I; Seemueller F; Dittmann S; Grunze H;
- Institution
- Journal
- J Clin Psychopharmacol. 2007 Feb;27(1):104-6.
24. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.
- Author
- Weiss RD; Griffin ML; Kolodziej ME; Greenfield SF; Najavits LM; Daley DC; Doreau HR; Hennen JA;
- Institution
- Department of Psychiatry, Harvard Medical School, Boston, and McLean Hospital, 115 Mill St., Belmont, MA 02478, USA. rweiss@mclean.harvard.edu
- Journal
- Am J Psychiatry. 2007 Jan;164(1):100-7.
- Abstract URL
- Click here to view abstract
Next: Suicide Risk
